These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12204522)
1. Controlling the effectiveness of digoxin. Krohn BG J Am Coll Cardiol; 2002 Aug; 40(4):836; author reply 836-7. PubMed ID: 12204522 [No Abstract] [Full Text] [Related]
2. [Lower digitalis dosage in heart failure]. Madsen S; Holene E Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1053-4. PubMed ID: 17457392 [No Abstract] [Full Text] [Related]
3. [Posologic factors of digoxin in Catalonia]. Navarro Moreno LA; Maldonado Pardo R; García González I; Reig Puig L An Med Interna; 1999 Oct; 16(10):543-4. PubMed ID: 10603679 [No Abstract] [Full Text] [Related]
4. Digoxin may reduce the mortality rates in patients with congestive heart failure. Wang L; Song S Med Hypotheses; 2005; 64(1):124-6. PubMed ID: 15533628 [TBL] [Abstract][Full Text] [Related]
5. Low-dose digoxin in patients with heart failure. Less toxic and at least as effective? van Veldhuisen DJ J Am Coll Cardiol; 2002 Mar; 39(6):954-6. PubMed ID: 11897435 [No Abstract] [Full Text] [Related]
6. Therapeutic drug monitoring of digoxin-20 years of experience. Grześk G; Stolarek W; Kasprzak M; Krzyżanowski M; Szadujkis-Szadurska K; Wiciński M; Grześk E Pharmacol Rep; 2018 Feb; 70(1):184-189. PubMed ID: 29414149 [TBL] [Abstract][Full Text] [Related]
7. Clinical benefits of low serum digoxin concentrations in heart failure. Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434 [TBL] [Abstract][Full Text] [Related]
8. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure. Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482 [No Abstract] [Full Text] [Related]
9. Optimal digoxin concentrations for patients with heart failure. Carbonin P; Zuccalà G JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771104 [No Abstract] [Full Text] [Related]
10. [Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods]. Barros IC; Freitas EM; Rassi S; Carneiro WJ; Rodrigues CR; Honório TC; Teixeira Lde S; Rodríguez V; Cunha LC Farm Hosp; 2014 Jan; 38(1):38-43. PubMed ID: 24483858 [No Abstract] [Full Text] [Related]
11. Study of digoxin use in a public health unit. Souza FC; Marques EB; Scaramello RB; Christianne BV An Acad Bras Cienc; 2015; 87(2):1033-40. PubMed ID: 25993358 [TBL] [Abstract][Full Text] [Related]
12. Dilated cardiomyopathy and potentially deadly digoxin. Opie LH S Afr Med J; 2011 May; 101(6):388, 390. PubMed ID: 21920082 [No Abstract] [Full Text] [Related]
13. Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients. Kurzawski M; Bartnicka L; Florczak M; Górnik W; Droździk M Pharmacol Rep; 2007; 59(1):107-11. PubMed ID: 17377214 [TBL] [Abstract][Full Text] [Related]
15. Reference laboratory values for digoxin following publication of Digitalis Investigation Group (DIG) trial data. Hauptman PJ; McCann P; Romero JM; Mayo M JAMA Intern Med; 2013 Sep; 173(16):1552-4. PubMed ID: 23797613 [No Abstract] [Full Text] [Related]
16. [Digoxin plasma levels in four different prescription schedules of common use in clinical practice]. Reinbach R; Villa L; Giraudo P; Venegas R; Fernández P Rev Med Chil; 2003 Apr; 131(4):373-80. PubMed ID: 12870231 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic ranges of serum digoxin concentrations in patients with heart failure. Goldberger ZD; Goldberger AL Am J Cardiol; 2012 Jun; 109(12):1818-21. PubMed ID: 22502901 [No Abstract] [Full Text] [Related]